-
Janney: Nightstar Therapeutics Has 'Significant Upside Potential' With Retinal Disorder Treatments
Wednesday, August 22, 2018 - 10:21am | 410Read More...Nightstar Therapeutics PLC (NASDAQ: NITE) leads the market in adeno-associated virus gene therapy for the treatment of inherited retinal disorders, according to a bullish Janney analyst. The Analysts Analyst Yun Zhong initiated coverage of Nightstar with a Buy rating and $34 price...
-
Low Volume, High Returns for These ETFs (BIB, FHC, DRW)
Friday, July 13, 2012 - 3:25pm | 676Read More...Despite the rapid expansion of exchange-traded products to nearly 1,500 ETFs and ETNs combined, a percentage of products continues to dominate in terms of average daily volume. Indeed, TrimTabs Investment Research reported that the largest ETFs represent 15 percent of total daily stock trading...
-
UVFT.OB Selected by Award Winning Hotel to Provide UV-400 Air Purifier
Tuesday, October 19, 2010 - 12:58pm | 1044Read More...Biotech/Pharma Stock News; UV Flu Technologies (OTCBB: UVFT) Selected by Award Winning Hotel to Provide UV-400 Air Purifier to Launch NEW Hypo-Allergenic Guest Room Program CENTERVILLE, MA - October 19, 2010 (Investorideas.com newswire) UV Flu Technologies, Inc. (OTC.BB:UVFT) (the "Company") is...
